The future of FMD


L-Nutra holds the rights to the only patent in the history of healthcare on optimizing longevity and healthspan.

L-Nutra holds the rights to the only patent where the fasting condition is used as a dietary treatment of diabetes.

The founder of L-Nutra, Dr. Valter Longo, generously donates all profits from his 60% share in L-Nutra to the Create Cures Foundation

Our Mission

Recent breakthrough science has uncovered the power of fasting as a way to optimize the body’s aging process and disrupt chronic diseases such as obesity, diabetes, cancer, autoimmune disorders, Alzheimer’s and cardiovascular disease.

Our mission is to educate the world about the health benefits of fasting and introduce it back into the human diet in a safe and effective way via the Fasting Mimicking Diet (FMD).

Pipeline Products

The following ProLon variation products are under active development. They are all undergoing clinical trials at the moment.

  • Xentigen for Dietary Support of Cancer Symptoms Management
  • FMD AI for Dietary Treatment of Auto Immune Disease
  • FMD AD for Dietary Treatment of Alzheimer’s Disease
  • FMD Diabetes for Dietary Treatment of Diabetes